BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7481653)

  • 21. Hypertrophic cardiomyopathy: therapeutic approaches.
    Thomas B
    Heart Dis; 1999; 1(2):91-7. PubMed ID: 11720609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The best of cardiac pacing in 1999].
    Deharo JC
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1 Spec No):43-9. PubMed ID: 10721447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doppler evaluation of the descending aorta in patients with hypertrophic cardiomyopathy: potential for assessing the functional significance of outflow tract gradients and for optimizing pacemaker function.
    Mickelsen S; Bathina M; Hsu P; Holmes J; Kusumoto FM
    J Interv Card Electrophysiol; 2004 Aug; 11(1):47-53. PubMed ID: 15273454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pacing in hypertrophic cardiomyopathy.
    Kappenberger L
    Eur Heart J; 1999 Feb; 20(3):169-70. PubMed ID: 10082148
    [No Abstract]   [Full Text] [Related]  

  • 25. [The new indications for permanent cardiac pacing].
    Duarte JA; Carrageta M
    Rev Port Cardiol; 1999 Mar; 18(3):281-8. PubMed ID: 10335093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
    Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Doppler sonography assessment of blood flow velocity in the ascending aorta. Problems and possible solutions].
    Vieli A; Jenni R; Moser U; Casty M; Anliker M
    Ultraschall Med; 1987 Apr; 8(2):64-9. PubMed ID: 2956680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of hemodynamics with special reference to compliance and constant volume elasticity in healthy persons and in patients with hypertrophic obstructive cardiomyopathy, coronary disease and aortic valve insufficiency].
    Kornacewicz-Jach Z
    Pol Tyg Lek; 1987 Mar; 42(10):283-6. PubMed ID: 3601751
    [No Abstract]   [Full Text] [Related]  

  • 29. [The therapeutic focus in severe hypertrophic obstructive cardiomyopathy with multivessel coronary disease].
    Tascón Pérez JC; González-Trevilla AA; Gutiérrez MA; Dussac JA; Hernández Hernández F; Sánchez Sánchez V; Rodríguez García J
    Rev Esp Cardiol; 1999 May; 52(5):343-7. PubMed ID: 10368586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute and chronic sequential atrioventricular pacing in patients with obstructive-type hypertrophic myocardiopathy resistant to medical therapy].
    Rodrigues JC; Ferreira T; Calaça J; Matias F; Cardim N; Gouveia D; Figueiredo H; Correia JF
    Rev Port Cardiol; 1995 Sep; 14(9):637-41. PubMed ID: 7576764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term benefits of pacing in obstructive hypertrophic cardiomyopathy.
    Mohiddin SA; Page SP
    Heart; 2010 Mar; 96(5):328-30. PubMed ID: 19934102
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamic benefits of treatment modalities for hypertrophic cardiomyopathy: a case study.
    Evangelista LS; Chen J
    J Cardiovasc Nurs; 2001 Jan; 15(2):33-40. PubMed ID: 11140422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dual-chamber pacing in hypertrophic cardiomyopathy without obstruction.
    Hochleitner M; Hörtnagl H; Hörtnagl H; Gschnitzer F
    Lancet; 1992 Aug; 340(8815):369-70. PubMed ID: 1353827
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypertrophic obstructive cardiomyopathy. (Idiopathic hypertrophic subvalvular aortic stenosis)].
    Grouls V; Helpap B
    Med Welt; 1979 Jun; 30(25):985-8. PubMed ID: 572464
    [No Abstract]   [Full Text] [Related]  

  • 35. Pacing and hypertrophic cardiomyopathy.
    Lerakis S; Cohen D; Schwartz RA; Sheahan RG
    Am J Med Sci; 2001 Sep; 322(3):156-9. PubMed ID: 11572218
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pacemaker in hypertrophic obstructive cardiomyopathy. A new efficient treatment of heart disease].
    Gadler F; Juhlin-Dannfelt A; Linde C; Ribeiro A; Rydén L
    Lakartidningen; 1996 Oct; 93(41):3566-8; 3571-2. PubMed ID: 8965513
    [No Abstract]   [Full Text] [Related]  

  • 37. [Idiopathic hypertrophic subaortic stenosis].
    Rasmussen K; Aslaksen BB
    Nord Med; 1968 Jun; 79(24):769-75. PubMed ID: 5748627
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influencing of the muscular subaortic stenosis by intraventricular stimulus propagation].
    Rothlin M; Moccetti T
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():411-5. PubMed ID: 5168770
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic control of a threatening stage of idiopathic hypertrophic subaortic stenosis].
    Hassenstein P; Wolter HH
    Verh Dtsch Ges Kreislaufforsch; 1967; 33():242-6. PubMed ID: 5630206
    [No Abstract]   [Full Text] [Related]  

  • 40. [Improvement of hemodynamics by thoracic epidural anesthesia in a patient with hypertrophic obstructive cardiomyopathy].
    Asano S; Kawazoe T; Higa M; Noguchi J; Kaneko S
    Masui; 1987 Aug; 36(8):1299-303. PubMed ID: 3430709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.